ArticleThe ISME journal2026
Polystyrene-degrading bacteria modulate host stress and toxicity responses to microplastic exposure in Caenorhabditis elegans.
Article in The ISME journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Microplastic exposure is an emerging health risk. Host-associated plastic-degrading commensal bacteria can directly interact with microplastic particles and alter them physically and chemically, thereby potentially modulating microplastic toxicity. Despite numerous reports of plastic-degrading bacteria isolated from host intestines, how these interactions affect host physiology remains unclear. Here, we compared two polystyrene-degrading bacteria-Enterobacter hormaechei LG3 and Bacillus amyloliquefaciens SCGB1-in Caenorhabditis elegans exposed to laboratory-manufactured 1-μm polystyrene microspheres (Mi-PS). LG3-fed worms showed dose-dependent physiological impairment in response to Mi-PS, whereas SCGB1-fed worms exhibited attenuated or negligible impairment. The strains interacted with Mi-PS via distinct physiological and metabolic responses, reflected by differences in biofilm formation, particle attachment, and metabolite profiles. These strain-specific differences were confirmed to directly influence host outcomes. Under identical exposure conditions (10 mg/L, 50 h), LG3-fed worms accumulated more Mi-PS particles in the gut than SCGB1-fed worms (n = 48; mean ± SD, 3.28 ± 4.22 vs 0.63 ± 1.03 particles per worm). A transcriptome-guided validation framework provided mechanistic clues to strain-specific microplastic interactions. LG3-associated impairment coincided with the formation of oxidized Mi-PS particles, production of oxidized styrene intermediates, and microparticle-driven changes in bacterial cell properties, including activation of the lipopolysaccharide biosynthesis pathway. In contrast, SCGB1-associated attenuation was consistent with isobutyrate/isovalerate-mediated modulation of host DAF signaling. Collectively, these results link bacteria-microplastic interactions to host outcomes and offer actionable insight for assessing and mitigating microplastic-related health risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.